WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 25, 2016
Insider Transaction Report
Form 4
Bedwell Warwick
VP Pharma Pkgs Systems Asia Pa
Transactions
- Award
Common Stock
2016-02-23$59.64/sh+4,613$275,119→ 38,778.082 total - Exercise/Conversion
Common Stock
2016-02-23$54.14/sh+3,680$199,235→ 42,458.082 total - Exercise/Conversion
Common Stock
2016-02-24$47.34/sh+3,616$171,181→ 42,394.082 total - Sale
Common Stock
2016-02-24$59.23/sh−3,616$214,193→ 38,778.082 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-02-23$54.14/sh−3,680$199,235→ 11,040 totalExercise: $54.14From: 2016-02-23Exp: 2025-02-23→ Common Stock (3,680 underlying) - Award
Stock Option (Right to Buy)
2016-02-23$59.64/sh+13,012$776,036→ 13,012 totalExercise: $59.64From: 2017-02-23Exp: 2026-02-23→ Common Stock (13,012 underlying) - Sale
Common Stock
2016-02-23$58.84/sh−3,680$216,533→ 38,778.082 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-02-24$47.34/sh−3,616$171,181→ 7,232 totalExercise: $47.34From: 2015-02-24Exp: 2024-02-24→ Common Stock (3,616 underlying)
Footnotes (4)
- [F1]Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.
- [F2]This was multiple transactions on the same date with prices in the range of $58.69 to $58.98. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
- [F3]This was multiple transactions on the same date with prices in the range of $59.01 to $59.40. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
- [F4]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.